glucose, (beta-d)-isomer and Agammaglobulinemia
glucose, (beta-d)-isomer has been researched along with Agammaglobulinemia in 11 studies
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (90.91) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Dieppe, PA; Doherty, M; Whicher, JT | 1 |
Ruddy, S; Schenkein, HA | 1 |
Cole, PJ; Easmon, CS; Hastings, MJ; Williams, AJ | 1 |
Cheson, BD; Morris, SE | 1 |
Brown, DL; Lachmann, PJ; Unsworth, DJ; Würzner, R | 1 |
Eveland, LK; Greenblatt, HC; Morse, SI | 1 |
Breckenridge, RT; Leddy, JP; Martin, SE; Rosenfeld, SI | 1 |
Austen, KF; Gigli, I; Koethe, S | 1 |
Bünning, G; Göbel, U; Nürnberger, W; Schroten, H; Wahn, V; Willers, R | 1 |
Adinolfi, M | 1 |
Gewurz, H; Good, RA; Mergenhagen, SE; Naff, G; Pickering, RJ; Snyderman, R | 1 |
Trials
1 trial(s) available for glucose, (beta-d)-isomer and Agammaglobulinemia
Article | Year |
---|---|
[Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. II. Zymosan opsonization is decreased and is not increased by IgG infusions].
Topics: Agammaglobulinemia; Chemotaxis, Leukocyte; Child; Complement System Proteins; Granulocytes; Humans; Immunoglobulin G; Infusions, Intravenous; Leukemia, Lymphoid; Luminescent Measurements; Opsonin Proteins; Phagocytosis; Zymosan | 1988 |
Other Studies
10 other study(ies) available for glucose, (beta-d)-isomer and Agammaglobulinemia
Article | Year |
---|---|
Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.
Topics: Agammaglobulinemia; Calcium Phosphates; Complement Activation; Complement C3; Complement Pathway, Alternative; Crystallization; Edetic Acid; Egtazic Acid; Humans; Inflammation; Magnesium; Uric Acid; Zymosan | 1983 |
The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
Topics: Agammaglobulinemia; Binding Sites; Complement Activation; Complement C3; Complement C3-C5 Convertases; Complement C3b Inactivator Proteins; Complement C5; Complement Factor B; Complement Pathway, Alternative; Globulins; Humans; Immunoglobulin G; Kinetics; Zymosan | 1981 |
Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
Topics: Adult; Agammaglobulinemia; Cells, Cultured; Chelating Agents; Humans; Luminescent Measurements; Neutrophils; Opsonin Proteins; Phagocytosis; Photometry; Saccharomyces cerevisiae; Temperature; Zymosan | 1980 |
The role of complement and IgG on zymosan opsonization.
Topics: Agammaglobulinemia; Complement Pathway, Alternative; Complement Pathway, Classical; Complement System Proteins; Humans; Immunoglobulin G; Luminescent Measurements; Opsonin Proteins; Zymosan | 1981 |
Extracts of wheat gluten activate complement via the alternative pathway.
Topics: Adult; Agammaglobulinemia; Antibodies, Monoclonal; Celiac Disease; Complement Activation; Complement Hemolytic Activity Assay; Complement Pathway, Alternative; Dermatitis Herpetiformis; Edetic Acid; Egtazic Acid; Enzyme-Linked Immunosorbent Assay; Female; Glutens; Humans; Male; Middle Aged; Plant Extracts; Triticum; Zymosan | 1993 |
Schistosoma mansoni: complement and cercarial tail loss during in vitro transformation.
Topics: Agammaglobulinemia; Animals; Complement Activation; Complement C3; Complement Pathway, Alternative; Complement System Proteins; Elapid Venoms; Immune Sera; Schistosoma mansoni; Sepharose; Zymosan | 1979 |
Responses of human platelets to immunologic stimuli: independent roles for complement and IgG in zymosan activation.
Topics: Agammaglobulinemia; Blood Platelets; Complement System Proteins; Fibrinogen; Humans; Immunoglobulin Fc Fragments; Immunoglobulin G; Platelet Aggregation; Serotonin; Zymosan | 1978 |
Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
Topics: Agammaglobulinemia; Animals; Antigen-Antibody Reactions; Complement C1; Complement C2; Complement C3; Complement System Proteins; Erythrocytes; Factor XI Deficiency; Factor XII; Guinea Pigs; Humans; Immune Sera; Properdin; Sheep; Snake Venoms; Time Factors; Zymosan | 1975 |
Some serological characteristics of normal incomplete cold antibody.
Topics: ABO Blood-Group System; Agammaglobulinemia; Antibodies; Dextrans; Escherichia coli; Hot Temperature; Humans; In Vitro Techniques; Infant, Newborn; Properdin; Salmonella; Streptococcus; Streptococcus pneumoniae; Umbilical Cord; Zymosan | 1965 |
Decreased properdin activity in acute glomerulonephritis.
Topics: Absorption; Acute Disease; Agammaglobulinemia; Complement System Proteins; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; Properdin; Zymosan | 1969 |